These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37097596)

  • 21. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19.
    Payus AO; Jeffree MS; Ohn MH; Tan HJ; Ibrahim A; Chia YK; Raymond AA
    Neurol Sci; 2022 Mar; 43(3):1533-1547. PubMed ID: 34853897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catching hold of COVID-19-related encephalitis by tracking ANGPTL4 signature in blood: An Editorial Highlight for "Endothelial cell biomarkers in critically ill COVID-19-patients with encephalitis": An Editorial Highlight for "Endothelial cell biomarkers in critically ill COVID-19-patients with encephalitis" on page 492.
    Chakraborty S; Basu A
    J Neurochem; 2022 Jun; 161(6):458-462. PubMed ID: 34967002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroimmunology of COVID-19].
    Skripuletz T; Möhn N; Franke C; Prüß H
    Nervenarzt; 2021 Jun; 92(6):521-530. PubMed ID: 33651117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological Complications of Dengue Fever.
    Trivedi S; Chakravarty A
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):515-529. PubMed ID: 35727463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination.
    Vogrig A; Janes F; Gigli GL; Curcio F; Negro ID; D'Agostini S; Fabris M; Valente M
    Clin Neurol Neurosurg; 2021 Sep; 208():106839. PubMed ID: 34325334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients.
    Finsterer J; Scorza FA
    J Clin Neurosci; 2021 Aug; 90():140-143. PubMed ID: 34275539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.
    Sriwastava S; Tandon M; Podury S; Prasad A; Wen S; Guthrie G; Kakara M; Jaiswal S; Subedi R; Elkhooly M; Lisak RP
    J Neurol; 2021 Dec; 268(12):4448-4478. PubMed ID: 34009454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [COVID-19 and herpesvirus encephalitis].
    Ramírez-Colombres M; Maenza CE; Rocchetti NS; Gattino SP; Diodati S; Luchitta CA; Ré MD; Settecase CJ; Bagilet DH
    Rev Neurol; 2022 Apr; 74(8):280-283. PubMed ID: 35383876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
    Valencia Sanchez C; Theel E; Binnicker M; Toledano M; McKeon A
    Neurology; 2021 Dec; 97(23):e2262-e2268. PubMed ID: 34635560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy.
    Honore PM; Barreto Gutierrez L; Kugener L; Redant S; Attou R; Gallerani A; De Bels D
    Crit Care; 2020 Oct; 24(1):623. PubMed ID: 33092622
    [No Abstract]   [Full Text] [Related]  

  • 32. The case of encephalitis in a COVID-19 pediatric patient.
    Urso L; Distefano MG; Cambula G; Colomba AI; Nuzzo D; Picone P; Giacomazza D; Sicurella L
    Neurol Sci; 2022 Jan; 43(1):105-112. PubMed ID: 34668122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune-mediated encephalitis in a child with a history of SARS-CoV-2 infection].
    Adauto Luizaga J; Costa Almar F; Zwirner A; Fernández Polivanoff ML; Suárez RF; Rossi S; Pascual C
    Arch Argent Pediatr; 2022 Aug; 120(4):e183-e186. PubMed ID: 35900960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients.
    Veleri S
    Exp Brain Res; 2022 Jan; 240(1):9-25. PubMed ID: 34694467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Encephalitis following COVID-19 disease].
    Varannai L; Magyar Z; Baranyai B; Ajzner É; Czurkó M
    Ideggyogy Sz; 2021 Jul; 74(7-08):277-285. PubMed ID: 34370409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological consequences of COVID-19.
    Brola W; Wilski M
    Pharmacol Rep; 2022 Dec; 74(6):1208-1222. PubMed ID: 36180640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
    Zhang Y; Chen X; Jia L; Zhang Y
    Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central Nervous System Manifestations Associated with COVID-19.
    Divani AA; Andalib S; Biller J; Di Napoli M; Moghimi N; Rubinos CA; Nobleza CO; Sylaja PN; Toledano M; Lattanzi S; McCullough LD; Cruz-Flores S; Torbey M; Azarpazhooh MR
    Curr Neurol Neurosci Rep; 2020 Oct; 20(12):60. PubMed ID: 33128130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.
    D V; Sharma A; Kumar A; Flora SJS
    ACS Chem Neurosci; 2021 Aug; 12(15):2776-2797. PubMed ID: 34260855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.